Cardiac Biotech Solutions Inc. (CBSC)

Cardiac Biotech Solutions Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2018	FY 2017
Period Ending	Mar 10, 2026	Mar 31, 2018	Mar 31, 2017
Market Capitalization	6	17	100
Market Cap Growth	-31.31%	-82.86%	-
Last Close Price	0.04	0.30	1.75
PS Ratio	128.27	467.94	3032.81
PB Ratio	-4.68	-14.11	-192.88
Net Debt / Equity Ratio	0.01	0.00	0.02
Net Debt / EBITDA Ratio	-	0.00	0.03
Net Debt / FCF Ratio	-	0.01	0.20
Asset Turnover	-	0.57	-
Inventory Turnover	-	0.70	-
Quick Ratio	0.01	0.01	0.03
Current Ratio	0.03	0.02	0.07
Return on Assets (ROA)	-	-1103.12%	-
Return on Capital Employed (ROCE)	54.20%	93.20%	71.40%
Earnings Yield	-9.91%	-6.60%	-0.39%
FCF Yield	-	-4.51%	-0.06%
Buyback Yield / Dilution	-	-1.52%	-

Updated Mar 5, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.